Cargando…

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis

Detalles Bibliográficos
Autores principales:	Talty, Ronan, Damsky, William, King, Brett
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427262/ https://www.ncbi.nlm.nih.gov/pubmed/34522749 http://dx.doi.org/10.1016/j.jdcr.2021.08.012

Ejemplares similares

Treatment of Multiorgan Sarcoidosis With Tofacitinib
por: Damsky, William, et al.
Publicado: (2020)

Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
por: Talty, Ronan, et al.
Publicado: (2022)

Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
por: Damsky, William, et al.
Publicado: (2016)

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
por: Singh, Katelyn, et al.
Publicado: (2020)

Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
por: Kim, Sa Rang, et al.
Publicado: (2018)

Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
por: Damsky, William, et al.
Publicado: (2022)

Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
por: Damsky, William, et al.
Publicado: (2020)

Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil
por: Alam, Mariam, et al.
Publicado: (2020)

Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera
por: Wei, Jenny J., et al.
Publicado: (2019)

Treatment of granuloma annulare with tofacitinib 2% ointment
por: Damsky, William, et al.
Publicado: (2019)

The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature
por: Wang, Alice, et al.
Publicado: (2020)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment
por: Costanza, Marco B., et al.
Publicado: (2023)

Cutaneous Manifestations of Sarcoidosis
por: Dogra, Alka, et al.
Publicado: (2012)

Erythrodermic scabies in an immunocompetent patient
por: Talty, Ronan, et al.
Publicado: (2022)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
por: Smith, Jeffrey S., et al.
Publicado: (2023)

Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib
por: Ni, Han, et al.
Publicado: (2013)

Impact of Janus Kinase Inhibition with Tofacitinib on Fundamental Processes of Bone Healing
por: Gaber, Timo, et al.
Publicado: (2020)

The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Peterson, Danielle, et al.
Publicado: (2020)

Morpheaform sarcoidosis: A case presentation of an uncommon cutaneous manifestation of sarcoidosis
por: Hashemi, Kimberly B., et al.
Publicado: (2021)

Isolated facial cutaneous sarcoidosis
por: Kumar, Sumir, et al.
Publicado: (2012)

Ultrasound findings in cutaneous sarcoidosis
por: Dybiec, Ewa, et al.
Publicado: (2015)

Musculoskeletal and cutaneous sarcoidosis: exuberant case report()
por: Haddad, Natalie, et al.
Publicado: (2014)

Cutaneous Sarcoidosis Clinically Mimicking Necrobiosis Lipoidica in a Patient with Systemic Sarcoidosis
por: Chiba, Takahito, et al.
Publicado: (2012)

Comorbidity of Leishmania Major with Cutaneous Sarcoidosis
por: Moravvej, Hamideh, et al.
Publicado: (2014)

Cutaneous sarcoidosis simulating porokeratosis of Mibelli
por: Elfatoiki, Fatima Zahra, et al.
Publicado: (2015)

Annular cutaneous sarcoidosis with systemic involvement
por: Mishra, Ajay Kumar, et al.
Publicado: (2017)

Sarcoidosis and cutaneous lymphoma: What is the relationship?
por: Gargallo, Vanessa, et al.
Publicado: (2017)

Cutaneous sarcoidosis with livedo-like manifestation
por: Bittencourt, Maraya de Jesus Semblano, et al.
Publicado: (2019)

Prevalence and characteristics of cutaneous sarcoidosis in Argentina
por: Abed Dickson, Marina, et al.
Publicado: (2021)

Atypical Protean Manifestations of Cutaneous Sarcoidosis
por: Arora, Pooja, et al.
Publicado: (2022)

Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2020)

Cutaneous sarcoidosis masquerading as chronic cutaneous lupus erythematosus - case report
por: Vatanchi, Marjon, et al.
Publicado: (2016)

Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
por: Berbert Ferreira, Sineida, et al.
Publicado: (2021)

HISTOPLASMOSIS IN PATIENT WITH SARCOIDOSIS
por: Wooten, William, et al.
Publicado: (2020)

Unusual Case of Scalp Sarcoidosis with Alopecia: An Only Manifestation of Cutaneous Sarcoidosis without Systemic Involvement
por: Kim, Jin Cheol, et al.
Publicado: (2022)

Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
por: Yamamura, Yuriko, et al.
Publicado: (2019)

Adaptive Immune Responses in Primary Cutaneous Sarcoidosis
por: Bordignon, Matteo, et al.
Publicado: (2011)

Cutaneous Sarcoidosis: A Case of the Great Imitator
por: Hayati, Firdaus, et al.
Publicado: (2020)

Multifocal Cutaneous Sarcoidosis Presenting as Lid Ectropion
por: Kamat, Divya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_darhkgplcm3kougmgp9141qbrm